mercaptopurine bnm
boucher & muir (new zealand) limited t/a bnm group - mercaptopurine 50mg - tablet - 50 mg - active: mercaptopurine 50mg excipient: lactose magnesium stearate maize starch pregelatinised maize starch stearic acid - mercaptopurine is indicated for the treatment of acute leukaemia in adults, adolescents and children. it may be utilised in remission induction and is particularly indicated for maintenance therapy in: · acute lymphoblastic leukaemia; · acute myelogenous leukaemia.
allmercap
link pharmaceuticals ltd - mercaptopurine 20 mg/ml - oral suspension - 20 mg/ml - active: mercaptopurine 20 mg/ml excipient: aspartame potassium sorbate purified water raspberry flavour - concentrated juice (nova) sodium ethyl hydroxybenzoate sodium hydroxide sodium methyl hydroxybenzoate xanthan gum - allmercap is indicated for the treatment of acute lymphoblastic leukaemia (all) in paediatric patients.
mercaptopurine 100mg5ml oral suspension
special order - mercaptopurine - oral suspension - 20mg/1ml
mercaptopurine 25mg5ml oral suspension
special order - mercaptopurine - oral suspension - 5mg/1ml
mercaptopurine 10mg capsules
special order - mercaptopurine - capsule - 10mg
mercaptopurine 50mg tablets
waymade healthcare plc - mercaptopurine - tablet - 50mg
mercaptopurine 50mg5ml oral suspension
special order - mercaptopurine - oral suspension - 10mg/1ml
mercaptopurine 5mg5ml oral suspension
special order - mercaptopurine - oral suspension - 1mg/1ml
mercaptopurine 75mg5ml oral suspension
special order - mercaptopurine - oral suspension - 15mg/1ml
mercaptopurine 10mg tablets
special order - mercaptopurine - tablet - 10mg